Previous Article | Next Article 
Journal of Virology, September 2000, p. 8558-8562, Vol. 74, No. 18
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Interaction of Cellular Proteins with the 5' End
of Norwalk Virus Genomic RNA
Ana Lorena
Gutiérrez-Escolano,1,*
Zamirath Uribe
Brito,1
Rosa M.
del Angel,1 and
Xi
Jiang2
Departamento de Patología Experimental, Centro de
Investigación y de Estudios Avanzados del IPN, Mexico City,
Mexico,1 and Center for Pediatric
Research, Children's Hospital for the King's Daughters, Eastern
Virginia Medical School, Norfolk, Virginia2
Received 29 February 2000/Accepted 20 June 2000
 |
ABSTRACT |
The lack of a susceptible cell line and an animal model for Norwalk
virus (NV) infection has prompted the development of alternative strategies to generate in vitro RNAs that approximate the authentic viral genome. This approach has allowed the study of viral RNA replication and gene expression. In this study, using mobility shift
and cross-linking assays, we detected several cellular proteins from
HeLa and CaCo-2 cell extracts that bind to, and form stable complexes
with, the first 110 nucleotides of the 5' end of NV genomic RNA, a
region previously predicted to form a double stem-loop structure. These
proteins had molecular weights similar to those of the HeLa cellular
proteins that bind to the internal ribosomal entry site of poliovirus
RNA. HeLa proteins La, PCBP-2, and PTB, which are important for
poliovirus translation, and hnRNP L, which is possibly implicated in
hepatitis C virus translation, interact with NV RNA. These protein-RNA
interactions are likely to play a role in NV translation and/or replication.
 |
INTRODUCTION |
Norwalk virus (NV) is the prototype
strain of human caliciviruses and has been implicated in outbreaks of
nonbacterial acute gastroenteritis in the U.S. and many other countries
(2, 15, 30). The virus is small (27 to 35 nm in diameter),
round, nonenveloped, and with an amorphous surface structure (29,
40). The virion contains a 7.7-kb single-stranded, positive RNA
genome; the RNA is polyadenylated and attaches with a VPg at its 5' end
(6, 10). Genome sequence analysis has revealed three open
reading frames (ORFs). ORF 1 encodes a polyprotein that is processed
into nonstructural proteins required for virus replication and has sequence homology to picornavirus 2C helicase, 3C protease, and 3D
RNA-dependent RNA polymerase (12). ORF 2 encodes the viral capsid protein, and ORF 3 encodes a small basic protein with an unknown
function (27). NV also produces a 2.3-kb subgenomic RNA
containing ORFs 2 and 3, each of them having a strong AUG initiation
codon, suggesting that they may be expressed independently (27).
The conserved sequence identified at the 5' end of the genomic and
subgenomic RNAs of NV suggests that it might be important for virus
replication; 23 (88%) of the first 26 nucleotides (nt) of the two RNAs
are identical (20). This element is also present in other
caliciviruses, including the rabbit hemorrhagic disease virus and the
feline calicivirus (9, 20, 34, 42). Sequence analysis of the
NV RNA predicted a double stem-loop structure at the 5' end of the
genomic (nt 1 to 110) and subgenomic (nt 5280 to 5356) RNAs
(27). A similar double stem loop was also predicted upstream
of ORF 3 (nt 6848 to 6941). However, the role of these predicted
structures in viral RNA replication remains unknown.
Highly conserved secondary RNA structures are known to be present at
the 5' and 3' ends or in the internal regions of the genomes of
picornaviruses, hepatitis C virus, dengue virus, Japanese encephalitis
virus, and simian hemorrhagic fever virus (7, 8, 11, 13, 22, 24,
28, 34, 38, 43, 47). Studies of viral RNA interaction with
cellular proteins have identified several elements in the viral RNAs
that are important for viral replication (1, 3, 13).
RNA-protein complexes are formed when authentic viral RNA or in vitro
synthesized viral RNA transcripts are incubated with cell extracts.
These complexes are involved in viral RNA replication and translation
(1, 7, 8, 13, 17, 19, 22, 23, 24, 25, 28, 33, 43, 47, 48).
The absence of a permissive cell line and a susceptible animal model
for NV infection has made it difficult to study the biology of the
virus. The successful cloning and sequencing of the NV genome and other
human calicivirus genomes has allowed much progress in our knowledge of
gene coding strategies, genomic organization, viral RNA replication,
and gene expression (20, 26, 27, 34). However, in the case
of NV little is known about the mechanisms of viral replication. In
this study, we performed binding experiments of in vitro synthesized NV
RNA and HeLa and CaCo-2 cell extracts. Our results demonstrate that the
5' end of the NV genome contains elements that bind specifically to
different cellular proteins, some of which include HeLa proteins, such
as La, hnRNPL, PTB, and PCBP-2, that are known to be involved in the
poliovirus internal ribosomal entry site (IRES)-associated translation
(3, 16, 17, 19, 21, 28, 34, 35, 36) and hepatitis C
virus translation (18, 23).
 |
MATERIALS AND METHODS |
Cells.
HeLa cells were grown in Dulbecco's minimal
essential medium supplemented with 10% newborn calf serum, 5,000 U of
penicillin, and 5 µg of streptomycin. CaCo-2 cells (a human colon
adenocarcinoma cell line) were grown in Dulbecco's minimal essential
medium containing 0.11% glutamine, 0.02% sodium pyruvate, 0.47%
NaCl, 1× nonessential amino acids, 5,000 U of penicillin, 5 µg of
streptomycin, and 10% fetal bovine serum. Both cell lines were grown
in a 5% CO2 incubator at 37°C. The culture medium was
changed every other day until the cells reached confluency.
Subcloning of the 5' end of NV genomic cDNA.
A cDNA clone of
nt 1 to 1810 of the NV genome was constructed from the cDNA clone 5030 (27) by PCR using a 5' primer containing the first 12 nt of
the NV genome that were missed in cDNA 5030 and a 3' primer containing
the sequence around the EcoRV site at nt 1810 of the NV
genome. To facilitate synthesis of RNA using this cDNA as a template, a
bacteriophage T7 RNA promoter sequence and a MluI site were
included in the 5' primer. The PCR-amplified 1.8-kb cDNA was
subsequently cloned into a pGEM-T vector (Promega).
In vitro transcription of 5' NV genomic RNAs.
NV genomic
RNAs containing nt 1 to 191 were prepared by in vitro transcription
using T7 RNA polymerase with the NV 1.8-kb cDNA predigested with
MluI and HaeII as a template, following a method
previously described (38). After the transcription reaction,
the DNA template was removed by treating the samples with DNase RQ1
(Promega) in the presence of RNase inhibitors (Promega). Unincorporated
nucleotides in the reaction mixture were removed by gel filtration. For
synthesis of radiolabeled RNA transcripts, [
-32P]UTP
(Dupont) was included in the transcription reaction.
Two additional RNAs containing nt 1 to 110 and 111 to 191 of the NV
genome were produced by in vitro transcription using T7 RNA polymerase
from the two PCR-amplified cDNAs containing the respective regions. The
PCR was performed using the NV 1.8-kb cDNA as the template. The 5'
primers of the two pairs used in the PCR also contained the
bacteriophage T7 promoter sequence. The PCR was performed for 35 cycles
of 94°C for 1 min, 56°C for 1 min, and 72°C for 30 s, using
a Perkin-Elmer Cetus DNA thermocycler. The resulting PCR products were
purified by a QIAquiq gel extraction G-50 kit (Qiagen) before they were
used as templates for RNA synthesis.
Preparation of HeLa and CaCo-2 cell extracts.
HeLa and
CaCo-2 cells were washed twice with cold phosphate-buffered saline and
once with 5 volumes of washing buffer (10 mM HEPES [pH 7.9], 1.5 mM
MgCl2, 10 mM KCl). After the final wash, the cells were
resuspended in 2 cell volumes of washing buffer. HeLa cells were
homogenized with 20 strokes and CaCo-2 cells were homogenized with 60 strokes in a glass Dounce homogenizer. The cell homogenates were
centrifuged at 10,000 rpm for 30 min in a Sorvall GSA rotor. The
supernatant, called S10 extract, was divided into aliquots, and the
concentration of proteins in each extract was determined by the
Bradford assay (5).
Mobility shift electrophoresis assay.
Variable amounts (4 to
20 µg) of S10 extracts from HeLa or CaCo-2 cells were preincubated
for 15 min at 4°C with equal amounts of tRNA in a buffer containing
10 mM HEPES (pH 7.4), 0.1 mM EDTA, 0.2 mM dithiothreitol, 8 mM
MgCl2, 4 mM spermidine, 3 mM ATP, 2 mM GTP, and 10%
(vol/vol) glycerol in a final volume of 10 µl. For each RNA binding
experiment, 1 × 106 cpm of 32P-labeled NV
RNA was added to the reaction mixture and incubated for 15 min at
4°C. Before loading the gels, a final incubation with 20 units of
RNase A and 20 µg of RNase T1 was performed for 15 min at
room temperature. RNA-protein complexes were analyzed by
electrophoresis on a 6% polyacrylamide (acrylamide-bisacrylamide, 80:1) gel in 0.5× TBE buffer (90 mM Tris, 64.6 mM boric acid, 2.5 mM
EDTA [pH 8.3]) run at 20 mA for 4 h. Gels were dried and autoradiographed. To determine the stability of the RNA-protein complexes, different concentrations of KCl were included in the preincubation reaction. For competition experiments, unlabeled RNAs
were added to the preincubation reaction mixture.
Mobility supershift electrophoresis assay.
Twelve micrograms
of monoclonal antibodies to HeLa PCBP-2 protein were incubated with 12 µg of S10 extracts. The antigen-antibody reaction was allowed to
proceed for 30 min on ice before addition of labeled RNA. The
antibody-RNA-protein supercomplex was further processed under the same
conditions described for the RNA-protein complex. The monoclonal
antibodies were generously provided by B. Semler, University of
California, Irvine.
UV cross-linking of RNA-protein complex.
UV cross-linking of
RNA-protein complexes was performed using a method described previously
(16, 17) in a reaction mixture containing 200 pmol of
-32P-labeled RNA and 60 µg of S10 extract or 500 ng of
the recombinant polypyrimidine tract-binding (PTB) protein. The
recombinant PTB protein was kindly provided by Monica DeNova,
Centro de Investigación y de Estudios Avanzados del IPN,
Mexico City, Mexico. The sequence of the human PTB was obtained from
plasmid PTB-pRC/CMV (kindly provided by Stanley Lemon, University of
North Carolina). Following cross-linking, the samples were fractionated
in 10% sodium dodecyl sulfate (SDS)-polyacrylamide gels. The gels were
fixed, dried, and autoradiographed.
Immunoprecipitation of La-RNA and hnRNP-L-RNA complexes.
After UV cross-linking of CaCo-2 cytoplasmic extracts to nt 1 to 110 of
NV RNA and RNase treatment were done as described above, the samples
were incubated with 10 µl of protein G-Sepharose 4B beads for 2 h at 4°C and centrifuged at 12,000 rpm for 5 min in a
microcentrifuge. Supernatants were incubated overnight at 4°C with
monoclonal anti-La or anti-hnRNP-L antibodies (kindly provided by N. Sonenberg, McGill University, Montreal, Quebec, Canada, and G. Dreyfuss, University of Pennsylvania School of Medicine, Philadelphia,
respectively) overnight at 4°C. The immunocomplexes were immobilized
on protein G-Sepharose 4B beads saturated with 2% bovine serum albumin
for another 2 h at 4°C. Unbound materials were washed five times
with NETS buffer (50 mM Tris-HCl [pH 7.4], 5 mM EDTA, 1 mM
dithiothreitol, 100 mM NaCl, 0.05% Nonidet P-40). Bound proteins were
analyzed by SDS-polyacrylamide gel electrophoresis (PAGE) followed by
autoradiography. Parallel reaction mixtures were made with an unrelated
antiactin monoclonal antibody as a control.
 |
RESULTS |
Interaction of the 5' end of NV RNAs with cell extracts.
To
determine whether the 5' end of the NV genome was recognized by
cellular proteins, 32P-labeled RNA transcripts from nt 1 to
191 (including the predicted double stem loop of nt 1 to 110) were
incubated with the S10 extract from HeLa cells. A major RNA-protein
complex was observed following electrophoresis (Fig.
1). Similar results were obtained when
CaCo-2 extracts were used (data not shown). The migration of the
complex was retarded when increasing concentrations of S10 extracts
were used (Fig. 1A, lanes 2 to 4). Electrophoresis performed following RNase treatment showed the formation of three complexes with different migration patterns in both HeLa cells (Fig. 1B, lane 2) and CaCo-2 cells (lane 3). Complexes II and III revealed stronger RNA labeling than complex I in HeLa S10 extracts, while complexes I and II showed
stronger signals in CaCo-2 extracts.

View larger version (40K):
[in this window]
[in a new window]
|
FIG. 1.
Mobility shift analysis of RNA consisting of nt 1 to 191 from the NV 5' end. (A) Labeled RNA incubated in the absence (lane 1)
or presence of 2, 6, and 8 µg of HeLa S10 extracts (lanes 2, 3, and
4, respectively). (B) Labeled RNA incubated in the absence (lane 1) or
presence of 12 µg of HeLa (lane 2) or CaCo-2 S10 extracts (lane3),
followed by RNase treatment. Complex formation was assayed by
electrophoresis on native polyacrylamide gels and detected by
autoradiography. Mobility of complexes I, II, and III is indicated on
the right side of the figure.
|
|
In order to determine the stability of the RNA-protein complexes, the
samples were incubated with variable KCl concentrations.
The three
complexes formed with the HeLa S10 extract and nt 1
to 191 of NV RNA
were not altered in a range of 0 to 1.2 M KCl
(Fig.
2A, lanes 2 to 5). However, the intensity
of complex I formed
with the CaCo-2 S10 extract was reduced at 0.9 and
1.2 M of KCl
(Fig.
2B, lanes 4 and 5).

View larger version (34K):
[in this window]
[in a new window]
|
FIG. 2.
Stability of RNA-protein complexes formed with nt 1 to
191 of NV. Labeled RNA was incubated in the absence (lanes 1) or
presence of 0.6, 0.9, and 1.2 M KCl (lanes 3 to 5, respectively) with
HeLa (A) or CaCo-2 (B) S10 extracts. Complex formation was assayed by
electrophoresis on native polyacrylamide gels and detected by
autoradiography.
|
|
The specificity of the RNA-protein binding was further demonstrated in
competition experiments using HeLa (Fig.
3A) or CaCo-2
extracts (Fig.
3B)
incubated with a 20-fold-molar excess of cold
homologous or
heterologous RNAs as competitors. Significant reduction
of the three
RNA-protein complexes was observed in samples incubated
with homologous
(nt 1 to 191 from NV) (lanes 3) but not heterologous
RNA transcripts
from pBluescript plasmid DNA (lanes 5). Most interestingly,
a
heterologous RNA (nt 275 to 628) from poliovirus (PV) efficiently
competed with the NV RNA in the formation of complexes (lanes
4),
suggesting that both viruses could share the same cellular
machinery
for replication.

View larger version (35K):
[in this window]
[in a new window]
|
FIG. 3.
Specificity of RNA-protein complexes formed with nt 1 to
191 of NV. Labeled RNA was incubated in the absence (lanes 2) or
presence of a 20-fold-molar excess of a homologous (lanes 3) or
heterologous competitor consisting of poliovirus nt 275 to 628 RNA
(lanes 4) or pBluescript RNA (lanes 5). Free RNA was loaded on lanes 1. HeLa S10 extracts (A) and CaCo-2 S10 extracts (B) are shown. Complex
formation was assayed by electrophoresis through native polyacrylamide
gels and detected by autoradiography.
|
|
Identification of cellular proteins present in the RNA-protein
complexes.
To identify the cellular proteins present in the
RNA-protein complexes, labeled RNA containing nt 1 to 191 of NV RNA was
incubated with HeLa or CaCo-2 extracts, followed by UV-induced
cross-linking, and was analyzed on denaturing SDS-PAGE. Nine proteins
with apparent molecular masses of 110, 97, 85, 80, 75, 68, 60, 52, and
39 kDa were identified from both HeLa and CaCo-2 cells (Fig.
4A, lanes 2, and 3, respectively).
Although similar molecular weights were observed for both cell lines,
the relative intensities of individual proteins differed. The 97- and
68-kDa proteins were more intense in HeLa cell extracts (lane 2), while
the 75- and 39-kDa proteins were stronger in the CaCo-2 cell extracts
(lane 3). Cellular proteins with molecular masses similar to those of
proteins cross-linked to NV RNA also bound to the PV 5' untranslated
region (nt 275 to 628) RNA (Fig. 4A, lane 1), except for a 60-kDa
protein that was cross-linked to the NV RNA but not to the PV RNA.
However, the intensity of labeled proteins bound to the PV RNA was
generally weaker.

View larger version (46K):
[in this window]
[in a new window]
|
FIG. 4.
UV-induced cross-linking of HeLa and CaCo-2 S10 extracts
to labeled RNAs from nt 1 to 191, 1 to 110, and 111 to 191 of NV. (A)
Labeled RNA of nt 1 to 191 of NV (lanes 2 and 3) and nt 275 to 628 of
the PV 5' untranslated region (lane 1) were UV cross-linked with 60 µg of HeLa extracts (lanes 1 and 2) or CaCo-2 S10 extracts (lane 3).
(B) Labeled RNA consisting of nt 1 to 110 (lanes 1 and 2) and nt 111 to
191 (lane 3) were UV cross-linked with 60 µg of HeLa extracts (lane1)
or CaCo-2 S10 extracts (lanes 2 and 3). Proteins were separated by
SDS-12.5% PAGE and detected by autoradiography. Numbers to the right
of panels indicate molecular masses in kilodaltons.
|
|
To locate the specific region of the 5' end of the NV genome that is
responsible for the RNA-protein interactions, two RNA
probes consisting
of nt 1 to 110 (double stem loop) and nt 111
to 191 were used in the UV
cross-linking assays. The RNA probe
from nt 1 to 110 cross-linked with
the same nine proteins from
both HeLa (Fig.
4B, lane 1) and CaCo-2
(Fig.
4B, lane 2) cell
extracts that bound to the probe from nt 1 to
191 (Fig.
4A). In
contrast, the RNA probe from nt 111 to 191 failed to
cross-link
with any cellular proteins (Fig.
4B, lane 3), indicating
that
the protein interaction occurs within nt 1 to 110 of
NV.
Proteins of 97, 68, 57/60, 52, and 39 kDa bound to the PV IRES element
have been previously identified as unr, hnRNP L, PTB,
La, and PCBP2,
respectively. All of them are involved in picornavirus
and hepatitis C
virus translation (
3,
18,
21,
22,
23,
24,
28,
35,
36,
44).
Due to the similarities in molecular
mass to the proteins detected in
this study, the possibility of
the presence of PCBP-2, La, hnRNP-L, and
PTB was investigated.
To determine whether PCBP-2 binds to nt 1 to 110 of NV RNA, a
supershift assay was performed. Incubation with
anti-PCBP-2 antibodies
resulted in the formation of an additional
complex with less mobility
(Fig.
5A, lane
2) than the three complexes observed previously
(Fig.
5A, lane 1). This
additional complex was not formed when
the reaction was performed in
the presence of an unrelated antibody
(anti-actin) (Fig.
5A, lane 3).

View larger version (47K):
[in this window]
[in a new window]
|
FIG. 5.
Identification of proteins bound to nt 1 to 110 of NV
RNA. (A) Mobility supershift analysis of complexes formed with nt 1 to
110 of NV. Labeled RNA was incubated with 10 µg of HeLa S10 extracts
in the absence (lane 1) and presence of antibodies to PCBP-2 (lane 2)
or an antiactin antibody (lane 3). Complex formation was assayed by
electrophoresis through native polyacrylamide gels and detected by
autoradiography. The arrow indicates the complex formed in the presence
of the specific antibody. (B) Immunoprecipitation assay of La and
hnRNP-L proteins bound to nt 1 to 110 of NV RNA. Labeled RNA was
cross-linked with 60 µg of CaCo-2 S10 proteins (lanes 1 and 4) and
immunprecipitated with anti-La (lane 2), anti-hnRNP-L (lane 5) or
anti-actin antibodies (lanes 3 and 6). (C) UV cross-linking of nt 1 to
110 of NV RNA and nt 275 to 628 of PV RNA with S10 extracts from HeLa
and CaCo-2 cells and with the recombinant PTB protein. Labeled RNAs of
nt 1 to 110 of NV (lanes 1 to 3) and nt 275 to 628 of the PV 5' UTR
(lanes 4 to 6) were UV cross-linked with 60 µg of HeLa (lanes 1 and
4) or CaCo-2 (lane 2 and 5) S10 extract or 500 µg of recombinant PTB
protein (lanes 3 and 6). Samples were loaded on an SDS-10%
polyacrylamide gel followed by electrophoresis and were detected by
autoradiography.
|
|
To analyze if the 52- and 68-kDa cross-linked proteins correspond to
the La and hnRNP L proteins, an immunoprecipitation assay
using
monoclonal antibodies against each protein was carried out
(Fig.
5B). A
protein of 52 kDa that comigrates with the 52-kDa
cross-linked protein
was immunoprecipitated by anti-La antibodies
(Fig.
5B, lane 2), while a
68-kDa protein, which also migrates
with the 68-kDa cross-linked
protein, was identified by the anti-hnRNP
L antibodies (Fig.
5B, lane
5). Antiactin antibodies were unable
to immunoprecipitate any labeled
proteins (Fig.
5B, lanes 3 and
6).
Finally, a cross-linking assay of nt 1 to 110 of NV RNA with a
recombinant PTB protein was performed (Fig.
5C). The recombinant
PTB
was able to bind to nt 1 to 110 of NV RNAs and to nt 275 to
628 of PV
RNAs. However, this recombinant PTB showed a migration
slightly
different from that of the 57/60-kDa proteins cross-linked
with HeLa
and CaCo-2 cells with NV (Fig.
5C, lanes 1 and 2, respectively)
or PV
(Fig.
5C, lanes 4 and 5, respectively). The amount of labeled
PTB
detected when PV RNA was used was larger than the amount of
PTB bound
to NV
RNA.
 |
DISCUSSION |
This is the first report to show binding of NV RNA to proteins
from eukaryotic cells. Two different cell extracts were used. HeLa
cells were included in the study because they have been widely used for
cultivation of several viruses and contain the proteins and factors
required for their translation either in cell culture or in cell-free
systems (45). On the other hand, CaCo-2 cells (derived from
a human colon adenocarcinoma) were selected for their resemblance to
human enterocytes of the small intestine, where NV might replicate
during human infection (39, 40). Moreover, recombinant
NV-like particles, which are morphologically and antigenically similar
to native NV, bind and penetrate CaCo-2 cells (46).
In the absence of RNase, the mobility shift assays demonstrated the
formation of a large ribonucleoprotein complex with the 5' end of the
NV genome using HeLa and CaCo-2 S10 extracts. After RNase treatment
with HeLa or CaCo-2 S10 extracts, three ribonucleoprotein complexes were distinguished. There are several possibilities to
explain the presence of these bands: they might reflect (i) different
ribonucleoprotein complexes, (ii) the same complex with different
conformations, or (iii) three stages of the same complex with different
amounts of bound proteins. It is important to emphasize that these
complexes were not disrupted by increasing concentrations of KCl,
indicating that the RNA-protein interactions are stable.
The specificity of the complex formation was confirmed through the
competition with homologous but not with heterologous pBluescript RNA.
The competition observed in the presence of PV RNA suggests that NV and
PV probably use the same cellular machinery for replication. Although
the primary 5' end sequences of the two viral RNAs are different, the
specific competition suggests that they might share similar secondary
structures that are recognized by the same panel of proteins in these cells.
Since one of the three double stem-loop structures is predicted to be
located between nt 1 and 110 of NV RNA (27), we determined which of the cross-linked proteins that bound to nt 1 to 191 also bound
to this region. All HeLa and CaCo-2 cell proteins that bind to nt 1 to
191 formed complexes with NV nt 1 to 110, while no binding was observed
to nt 111 to 191, suggesting that the region from nt 1 to 110 is
responsible for the RNA-protein interaction. Similar double stem loops
are also predicted upstream of ORF 2 (nt 5280 to 5356) and ORF 3 (nt
6848 to 6941). Preliminary cross-linking assays performed with these
two regions suggest a protein binding pattern similar to the one
observed with nt 1 to 110 of NV RNA.
The cross-linking assays demonstrated the presence of nine proteins in
the NV RNA-protein complexes formed with the HeLa and CaCo-2 S10
extracts. Eight of these proteins had the same molecular mass as those
bound to nt 275 to 628 of PV RNA, providing further evidence that NV
and PV may use similar replication or translation mechanisms. The
57-kDa protein bound to PV RNA and identified as PTB (4, 14,
21) was detected in NV with a slightly higher migration. It is
then possible that the 60-kDa protein cross-linked to NV RNA could be
an isoform of PTB, as has been previously described (4, 14).
The recombinant PTB protein bound to PV RNA and NV RNA showed the same
migration, but the amount of protein bound to PV RNA was greater.
Although the reported PTB-binding consensus sequence is not present
within the first 110 nt of NV RNA, multiple binding sites of PTB have
been identified in PV and encephalomyocarditis virus IRES, where this
consensus sequence does not exist (24). It could be
speculated that PTB can bind to similar structures present in both RNAs
but with different affinity.
The presence of five favored initiation codons based on Kozak's rule
(31) has been reported within the first 1,106 nt of NV. The
first favored AUG is located at nt 11 and has been suggested to be the
translation initiation site (9). This site is very close to
the 5' end and might be inefficiently recognized or ignored by the
ribosome, as has been described previously (32). In
addition, the absence of the cap structure in NV RNA could suggest that the ribosome requires additional elements to initiate translation. One
possibility is that the observed ribonucleoprotein complex formed with
the double stem-loop structure located at nt 1 to 110 allows entry to
the ribosome, as occurs during picornavirus translation. In that case,
the next favored initiation codon located at nt 167 could be used as
the translation initiation site. La, hnRNP L, PTB, and PCBP-2 were
shown to interact with nt 1 to 110 of NV RNA by immunoprecipitation,
cross-linking, or mobility gel shift assays. La protein is responsible
for the selection of the correct translation initiation site and the
enhancement of PV translation (36). On the other hand, PTB
protein has been proposed to promote the correct folding of
encephalomyocarditis virus IRES in order to present the critical
primary nucleotide sequence motifs in the correct three-dimensional
organization to allow internal ribosome entry (28). For NV,
interaction with La and PTB could play a similar role, promoting the
correct folding of the RNA and selecting the correct site for ribosomal entry.
Although at present we do not know how NV RNAs interact with cellular
proteins, the formation of stable complexes with the 5' end of NV and
the identification of proteins related to PV replication and
translation in these complexes suggest that the RNA-protein
interactions could play a significant role in the translation of NV.
Further analysis aimed at understanding the role of the RNA-protein
interactions in viral translation or replication is currently being
performed in our laboratory using deletion and site-directed mutagenesis. Since HeLa cells contain translation factors that bind to
NV RNA, these cells could be used to analyze whether they allow NV
translation and shed some light on one of the processes of viral
replication. However, if NV translation can be demonstrated, this does
not mean that the complete viral cycle could take place in this cell
line. It is possible that other stages of the cycle, such as entrance,
RNA replication, or assembly, are blocked in these cells, thus
explaining their nonpermissive nature to NV.
 |
ACKNOWLEDGMENTS |
We thank Fernando Medina for the cell cultures, Jaime Escobar for
technical assistance, and Monica DeNova for the recombinant PTB
protein. We gratefully acknowledge Stanley Lemon for providing the PTB
sequence, B. Semler (University of California, Irvine) for the
anti-PCBP2 antibodies, N. Sonenberg (McGill University, Montreal,
Quebec, Canada) for the anti-La antibodies, and G. Dreyfuss (University
of Pennsylvania School of Medicine, Philadelphia) for the anti-hnRNP-L
antibodies. We also thank Martha Espinosa-Cantellano for critical
comments on the manuscript.
This work was supported by grants from the Consejo Nacional de Ciencia
y Tecnología.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Departamento de
Patología Experimental, Centro de Investigación y de
Estudios Avanzados del IPN, Av. IPN 2508, Col. San Pedro Zacatenco,
México, D.F. C.P. 07360, México. Phone: (52)5
747-3800, ext. 5647. Fax: (52)5 747-7107. E-mail:
alonso{at}mail.cinvestav.mx.
 |
REFERENCES |
| 1.
|
Andino, R.,
G. E. Rieckhof,
P. L. Achacoso, and D. Baltimore.
1993.
Poliovirus RNA synthesis utilizes an RNP complex formed around the 5' end of viral RNA.
EMBO J.
12:3587-3598[Medline].
|
| 2.
|
Blacklow, N. R., and H. B. Greenberg.
1991.
Viral gastroenteritis.
N. Engl. J. Med.
325:252-264[Medline].
|
| 3.
|
Blyn, L. B.,
J. S. Towner,
B. L. Semler, and E. Ehrenfeld.
1997.
Requirement of poly(rC) binding protein 2 for translation of poliovirus RNA.
J. Virol.
71:6243-6246[Abstract].
|
| 4.
|
Bothwell, A. L. M.,
D. W. Ballard,
W. M. Philbrick,
G. Lindwall,
S. E. Maher,
M. M. Bridgett,
S. F. Jamison, and M. A. Garcia-Blanco.
1991.
Purine polypyrimidine tract binding protein.
J. Biol. Chem.
25:24657-24663.
|
| 5.
|
Bradford, M. M.
1976.
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.
Anal. Biochem.
72:248-254[CrossRef][Medline].
|
| 6.
|
Burroughs, J. N., and F. Brown.
1978.
Presence of a covalently linked protein on calicivirus RNA.
J. Gen. Virol.
41:443-446[Abstract/Free Full Text].
|
| 7.
|
Chang, K. H.,
E. A. Brown, and S. M. Lemon.
1993.
Cell type-specific proteins which interact with the 5' nontranslated region of hepatitis A virus RNA.
J. Virol.
67:6716-6725[Abstract/Free Full Text].
|
| 8.
|
Chen, C. J.,
M. D. Kuo,
L. J. Chen,
S. L. Hsu,
Y. M. Wang, and J. H. Lin.
1997.
RNA-protein interactions: involvement of NS3, NS5, and 3' coding regions of Japanese encephalitis virus genomic RNA.
J. Virol.
71:3466-3473[Abstract].
|
| 9.
|
Clarke, I. N., and P. R. Lambden.
1997.
The molecular biology of caliciviruses.
J. Gen. Virol.
78:291-301[Medline].
|
| 10.
|
Dunham, D. M.,
X. Jiang,
T. Berke,
A. W. Smith, and D. O. Matson.
1998.
Genomic mapping of a calicivirus VPg.
Arch. Virol.
143:2421-2430[CrossRef][Medline].
|
| 11.
|
Ehrenfeld, E., and B. Semler.
1995.
Anatomy of the poliovirus internal ribosome entry site.
Curr. Top. Microbiol. Immunol.
203:65-83[Medline].
|
| 12.
|
Ehresmann, D. W., and F. L. Schaffer.
1977.
RNA synthesized in calicivirus-infected cells is atypical of picornaviruses.
J. Virol.
22:572-576[Abstract/Free Full Text].
|
| 13.
|
Gamarnik, A. V., and R. Andino.
1998.
Switch from translation to RNA replication in a positive-stranded RNA virus.
Genes Dev.
12:2293-2304[Abstract/Free Full Text].
|
| 14.
|
Gil, A.,
P. A. Sharp,
S. F. Jamison, and M. A. Garcia-Blanco.
1991.
Characterization of cDNAs encoding the polypyrimidine tract binding protein.
Genes Dev.
5:1224-1236[Abstract/Free Full Text].
|
| 15.
|
Greenberg, H. B.,
J. Valdesuso,
A. Z. Kapikian,
R. M. Chanock,
R. G. Wyatt,
W. Szmuness,
J. Larrick,
J. Kaplan,
H. Gilman, and D. A. Sack.
1979.
Prevalence of antibodies to the Norwalk virus in various countries.
Infect. Immun.
26:270-273[Abstract/Free Full Text].
|
| 16.
|
Gutiérrez-Escolano, A. L., and R. M. del Angel.
1996.
Nuclear proteins bind to poliovirus 5' untranslated region.
Arch. Med. Res.
27:413-419[Medline].
|
| 17.
|
Gutiérrez-Escolano, A. L.,
M. A. Denova,
V. R. Racaniello, and R. M. del Angel.
1997.
Attenuating mutations in the poliovirus 5' untranslated region alter its interaction with polypyrimidine tract-binding protein.
J. Virol.
71:3826-3833[Abstract].
|
| 18.
|
Hahm, B.,
Y. K. Kim,
J. H. Kim,
T. Y. Kim, and S. K. Jang.
1998.
Heterogeneous nuclear ribonucleoprotein L interacts with the 3' border of the internal ribosomal entry site of hepatitis C virus.
J. Virol.
72:8782-8788[Abstract/Free Full Text].
|
| 19.
|
Haller, A. A., and B. L. Semler.
1995.
Stem-loop structure synergy in binding cellular proteins to the 5' noncoding region of poliovirus RNA.
Virology
206:923-934[CrossRef][Medline].
|
| 20.
|
Hardy, M. E., and M. K. Estes.
1996.
Completion of the Norwalk virus genome sequence.
Virus Genes
12:287-290[Medline].
|
| 21.
|
Hellen, C. U.,
G. W. Witherella,
M. Schmid,
H. S. Shin,
T. V. Pestova,
A. Gil, and E. Wimmer.
1993.
A cytoplasmic 57-kDa protein that is required for translation of picornavirus RNA by internal ribosomal entry is identical to the nuclear pyrimidine tract-binding protein.
Proc. Natl. Acad. Sci. USA
90:7642-7646[Abstract/Free Full Text].
|
| 22.
|
Hunt, S. L.,
J. J. Hsuan,
N. Totky, and R. Jackson.
1998.
Unr, a cellular cytoplasmic RNA-binding protein with five cold-shock domains is required for internal initiation of translation of human rhinovirus RNA.
Genes Dev.
13:437-448[Abstract/Free Full Text].
|
| 23.
|
Hwang, Y. K., and M. A. Brinton.
1998.
A 68-nucleotide sequence within the 3' noncoding region of simian hemorrhagic fever virus negative-strand RNA binds to four MA104 cell proteins.
J. Virol.
72:4341-4351[Abstract/Free Full Text].
|
| 24.
|
Ito, T., and M. Lai.
1999.
An internal polypyrimidine-tract-binding site in the hepatitis C virus RNA attenuates translation, which is relieved by the 3' untranslated sequence.
Virology
254:288-296[CrossRef][Medline].
|
| 25.
|
Jackson, R. J., and A. Kaminski.
1995.
Internal initiation of translation in eukaryotes: the picornavirus paradigm and beyond.
RNA
1:985-1000[Medline].
|
| 26.
|
Jiang, X.,
M. Wang,
D. Y. Graham, and M. K. Estes.
1992.
Expression, self-assembly and antigenicity of the Norwalk virus capsid protein.
J. Virol.
66:6527-6532[Abstract/Free Full Text].
|
| 27.
|
Jiang, X.,
M. Wang,
K. Wang, and M. K. Estes.
1993.
Sequence and genomic organization of Norwalk virus.
Virology
195:51-61[CrossRef][Medline].
|
| 28.
|
Kaminski, A.,
S. L. Hunt,
J. G. Patton, and R. J. Jackson.
1995.
Direct evidence that polypyrimidine tract-binding protein (PTB) is essential for internal initiation of translation of encephalomyocarditis virus RNA.
RNA
1:924-938[Abstract].
|
| 29.
|
Kapikian, A. Z.,
R. G. Wyatt,
R. Dolin,
T. S. Thornhill,
A. R. Kalika, and R. M. Chanock.
1972.
Visualization by immune electron microscopy of a 27-nm particle associated with acute infectious nonbacterial gastroenteritis.
J. Virol.
10:1075-1081[Abstract/Free Full Text].
|
| 30.
|
Kaplan, J. E.,
G. W. Gary, and R. C. Baron.
1982.
Epidemiology of Norwalk gastroenteritis and the role of Norwalk virus in outbreaks of acute nonbacterial gastroenteritis.
Ann. Intern. Med.
96:756-761.
|
| 31.
|
Kozak, M.
1997.
Recognition of AUG and alternative initiator codons is augmented by G in position +4 but is not generally affected by nucleotides in positions +5 and +6.
EMBO J.
16:2482-2492[CrossRef][Medline].
|
| 32.
|
Kozak, M.
1991.
A short leader sequence impairs the fidelity of initiation by eucaryotic ribosomes.
Gene Expr.
1:111-115[Medline].
|
| 33.
|
Lai, M. M. C.
1998.
Cellular factors in the transcription and replication of viral RNA genomes: a parallel to DNA-dependent RNA transcription.
Virology
244:1-12[CrossRef][Medline].
|
| 34.
|
Lambden, P. R.,
B. Lui, and I. N. Clarke.
1995.
A conserved sequence motif at the 5' terminus of the Southampton virus genome is characteristic of the caliciviridae.
Virus Genes
10:149-152[CrossRef][Medline].
|
| 35.
|
Luz, N., and E. Beck.
1991.
Interaction of a cellular 57-kilodalton protein with the internal translation initiation site of foot-and-mouth disease virus.
J. Virol.
65:6486-6494[Abstract/Free Full Text].
|
| 36.
|
Meerovitch, K.,
Y. V. Svitkin,
H. S. Lee,
F. Lejbkowics,
D. J. Kenan,
E. K. L. Chan,
V. I. Agol,
J. D. Keene, and N. Sonenberg.
1993.
La autoantigen enhances and corrects aberrant translation of poliovirus RNA in reticulocyte lysate.
J. Virol.
67:3798-3807[Abstract/Free Full Text].
|
| 37.
|
Palmenberg, A. C.
1989.
Sequence alignments of picornaviral capsid proteins, p. 211-241.
In
B. L. Semler, and E. Ehrenfeld (ed.), Molecular aspects of picornavirus infection and detection. American Society for Microbiology, Washington, D.C.
|
| 38.
|
Pelletier, J.,
G. Kaplan,
V. R. Racaniello, and N. Sonenberg.
1988.
Cap-independent translation of poliovirus mRNA is conferred by sequence elements within the 5' noncoding region.
Mol. Cell. Biol.
8:1103-1112[Abstract/Free Full Text].
|
| 39.
|
Pintó, R. M.,
J. M. Diez, and A. Bosch.
1994.
Use of the colonic carcinoma cell line CaCo-2 for in vivo amplification and detection of enteric viruses.
J. Med. Virol.
44:310-314[Medline].
|
| 40.
|
Pintó, R. M.,
S. Robine-Leon,
M. D. Appay,
M. Kedinger,
N. Triadou,
E. Dussaulx,
B. Lacroix,
P. Simon-Assmann,
K. Haffen,
J. Fogh, and A. Zweibaum.
1983.
Enterocyte-like differentiation and polarization of the human colon carcinoma cell line Caco-2 in culture.
Biol. Cell
47:323-330.
|
| 41.
|
Prasad, B. V. V.,
R. Rothnagel,
X. Jiang, and M. K. Estes.
1994.
Three-dimensional structure of the baculovirus-expressed Norwalk virus capsid.
J. Virol.
68:5117-5125[Abstract/Free Full Text].
|
| 42.
|
Rinehart-Kim, J. E.,
W. M. Zhong,
X. Jiang,
A. W. Smith, and D. O. Matson.
1998.
Complete nucleotide sequence and genomic organization of a primate calicivirus, Pan-1.
Arch. Virol.
144:199-208.
|
| 43.
|
Roehl, H. H., and B. L. Semler.
1995.
Poliovirus infection enhances the formation of two ribonucleoprotein complexes at the 3' end of viral negative-strand RNA.
J. Virol.
69:2954-2961[Abstract].
|
| 44.
|
Svitkine, Y. V.,
K. Meerovitch,
H. S. Lee,
J. N. Dholakia,
D. J. Kenan,
V. I. Agol, and N. Sonenberg.
1994.
Internal initiation on poliovirus RNA: further characterization of La function in poliovirus translation in vitro.
J. Virol.
68:1544-1550[Abstract/Free Full Text].
|
| 45.
|
Villa-Komaroff, L.,
N. Gutteman,
D. Baltimore, and H. F. Lodish.
1975.
Complete translation of poliovirus RNA in a eukaryotic cell-free system.
Proc. Natl. Acad. Sci. USA
72:4157-4161[Abstract/Free Full Text].
|
| 46.
|
White, I. J.,
J. M. Ball,
M. E. Hardy,
T. N. Tanaka,
N. Kitamoto, and M. K. Estes.
1996.
Attachment and entry of recombinant Norwalk virus capsid to cultured human and animal cell lines.
J. Virol.
70:6589-6597[Abstract/Free Full Text].
|
| 47.
|
Witherell, G. W.,
A. Gil, and E. Wimmer.
1993.
Interaction of polypyrimidine tract binding protein with the encephalomyocarditis virus mRNA internal ribosomal entry site.
Biochemistry
32:8268-8275[CrossRef][Medline].
|
| 48.
|
Zeng, L.,
B. Falgout, and L. Markoff.
1998.
Identification of specific nucleotide sequences within the conserved 3'-SL in the dengue type 2 virus genome required for replication.
J. Virol.
72:7510-7522[Abstract/Free Full Text].
|
Journal of Virology, September 2000, p. 8558-8562, Vol. 74, No. 18
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Vashist, S., Anantpadma, M., Sharma, H., Vrati, S.
(2009). La protein binds the predicted loop structures in the 3' non-coding region of Japanese encephalitis virus genome: role in virus replication. J. Gen. Virol.
90: 1343-1352
[Abstract]
[Full Text]
-
Waggoner, S. A., Johannes, G. J., Liebhaber, S. A.
(2009). Depletion of the Poly(C)-binding Proteins {alpha}CP1 and {alpha}CP2 from K562 Cells Leads to p53-independent Induction of Cyclin-dependent Kinase Inhibitor (CDKN1A) and G1 Arrest. J. Biol. Chem.
284: 9039-9049
[Abstract]
[Full Text]
-
Thackray, L. B., Wobus, C. E., Chachu, K. A., Liu, B., Alegre, E. R., Henderson, K. S., Kelley, S. T., Virgin, H. W. IV
(2007). Murine Noroviruses Comprising a Single Genogroup Exhibit Biological Diversity despite Limited Sequence Divergence. J. Virol.
81: 10460-10473
[Abstract]
[Full Text]
-
Karakasiliotis, I., Chaudhry, Y., Roberts, L. O., Goodfellow, I. G.
(2006). Feline calicivirus replication: requirement for polypyrimidine tract-binding protein is temperature-dependent.. J. Gen. Virol.
87: 3339-3347
[Abstract]
[Full Text]
-
Waggoner, S. A., Liebhaber, S. A.
(2003). Identification of mRNAs Associated with {alpha}CP2-Containing RNP Complexes. Mol. Cell. Biol.
23: 7055-7067
[Abstract]
[Full Text]